Nivolumab Plus Chemoradiotherapy in Patients With Muscle-invasive Bladder Cancer (MIBC) Not Undergoing Cystectomy
Clinical trial NCT03993249 · UNKNOWN
Trial details
- NCT number
- NCT03993249
- Sponsor
- Hellenic GenitoUrinary Cancer Group
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-28
- Primary completion
- 2022-08-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.